Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for ACTH-Secreting Pituitary Adenoma

• A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
• SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
• Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
• Postoperative Thrombosis Prevention in Patients With CD
• Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
• Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
• Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Disease
• Open-label Treatment in Cushing's Syndrome
• Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
• Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment
• Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
• Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
• Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
• Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
• Treatment of Cushing's Disease With R-roscovitine
• Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
• Mifepristone in Children With Refractory Cushing's Disease
• Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
• Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
• An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
• Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
• Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
• Safety and Efficacy of LCI699 in Cushing's Disease Patients
• Prevention of Metabolic Complications of Glucocorticoid Excess
• Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
• Preoperative Bexarotene Treatment for Cushing's Disease
• Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
• Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
• Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
• A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease